SCHEMBL30336293

SCHEMBL30336293

CN(C)c1cc(Nc2ccc3c(c2)n(C)c(=O)n3C)cc(N(C)C)c1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.51
ALDH1A1 P00352 3/20 0.51
TP53 P04637 2/20 0.51
HSD17B10 Q99714 1/20 0.51
LMNA P02545 3/20 0.47
HTT P42858 1/20 0.47
GAA P10253 1/20 0.47
TRIM24 O15164 4/20 0.46
BCL6 P41182 2/20 0.45
XIAP P98170 1/20 0.45
BIRC2 Q13490 1/20 0.45
PKM P14618 4/20 0.44
BRPF1 P55201 2/20 0.42
BRD1 O95696 1/20 0.42
RAB9A P51151 1/20 0.42
BRD4 O60885 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24865703 1.00 SMN1; SMN2 (0.51) SMN1; SMN2ALDH1A1TP53HSD17B10LMNA
SCHEMBL24865206 0.89 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1TP53HSD17B10LMNA
SCHEMBL30336923 0.89 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1TP53HSD17B10LMNA
SCHEMBL30336657 0.88 SMN1; SMN2 (0.49) SMN1; SMN2ALDH1A1TP53HSD17B10LMNA
SCHEMBL24865387 0.88 SMN1; SMN2 (0.49) SMN1; SMN2ALDH1A1TP53HSD17B10LMNA
SCHEMBL24865481 0.78 TRIM24 (0.61) SMN1; SMN2ALDH1A1TP53HSD17B10LMNA
SCHEMBL30336496 0.77 ALDH1A1 (0.49) SMN1; SMN2ALDH1A1TP53HSD17B10LMNA
SCHEMBL24865219 0.77 ALDH1A1 (0.49) SMN1; SMN2ALDH1A1TP53HSD17B10LMNA
SCHEMBL24865065 0.74 ALDH1A1 (0.67) SMN1; SMN2ALDH1A1TP53HSD17B10LMNA
SCHEMBL24865394 0.74 BRPF1 (0.53) SMN1; SMN2ALDH1A1TP53HSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240327393-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2024-10-03 US disclosed
CN-117999259-A Iron death modulators, their preparation and use 维泰瑞隆有限公司 2024-05-07 CN disclosed
WO-2023280296-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2023-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240327393-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF AIFM2, GPX1, GPX4 SMN1; SMN2 1657/4885ALDH1A1 1306/4885TP53 1387/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.